James Marion

James Marion is a University of Houston student studying Business with a concentration in Finance. James has interned with several investment professionals and hopes to pursue a career as a professional stock analyst after graduation.

NetScout Systems (Nasdaq: NTCT) Beats Estimates and Shares Rise

Netscout Systems, Inc. – Nasdaq: NTCT

Shares of NetScout are higher after earnings beat street estimates. NTCT, traded on the Nasdaq, was expected to earn $0.55 EPS but NetScout came in at $0.60. The firm also reported a net income of $21.2 million after reporting a loss for the same period last year. NetScout develops, sells, and services application and network performance management products and solutions.

Anil Singhal, NETSCOUT’s president and CEO. “While the service provider spending environment remains muted, we are seeing momentum build for our newest offerings, including the software version of the InfiniStreamNG, our next-generation, real-time information platform. We have continued to execute well on our development roadmaps that align with a range of exciting opportunities spanning each of our major product areas and customer segments globally. As we move forward, we are focused on achieving our fiscal year 2017 financial, product and operational objectives while also setting the stage for further progress that can drive shareholder value in the next fiscal year.”

NetScout sales have increased year-on-year with the largest increase in 2016 when they reported sales of $955.4 million. EPS for NTCT had also increased year-on-year until 2016 when NTCT posted a loss of $$0.35. Eight firms follow NetScout Systems. Four rate NTCT shares as a “Strong Buy” and four rate the shares as a “Hold”. Their consensus price estimate for NTCT shares is $31.

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.

1/31/2017
Ticker Symbol NTCT
Last Price a/o 3:59 PM EST  $                    33.25
Average Volume                    651,860
Market Cap (mlns)  $              2,880.00
Sales (mlns) $1,130.00
Shares Outstanding (mlns) 91.57
Share Float (mlns) 87.78
Shortable Yes
Optionable Yes
Inside Ownership 0.60%
Short Float 10.08%
Short Interest Ratio 13.57
Quarterly Return 15.20%
YTD Return -0.16%
Year Return 45.94%

Avid Technologies (Nasdaq: AVID) Up on China Partnership

Avid Technology, Inc. – Nasdaq: AVID

Avid Technology announced today that they have entered into a partnership with their long-time partner in China, Beijing Jetsen Technology. The agreement makes Jetsen the exclusive (master) distributor in Greater China of Avid’s comprehensive tools and workflow solutions for creating, distributing and optimizing media. The news has sent AVID shares, traded on the Nasdaq, up 10% in early trading on heavy volumes.

Jetsen will distribute all Avid products and solutions in Greater China, including mainland China, Hong Kong, Macau and Taiwan, continuing to work closely and directly with Avid’s existing reseller network in the region. Supporting Avid’s strategies for the Greater China market, the agreement with Jetsen enables Avid to deliver on its commitment to providing its client community the most flexible deployment models, licensing options and commercial structures with future cloud and enterprise offerings for the region, as well as more localized and tailored solutions.

Since 2011, Avid Technologies have seen negative growth in both EPS and reported sales. In 2011 AVID sales were $766.9 million. That figure has decreased year-on-year and in 2015 AVID sales were $505.6 million. EPS for AVID shares a similar history – $4.23 in 2011 with decreasing EPS each year and $$0.06 EPS for AVID shareholders in 2015.

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.

 

Calithera Biosciences (Nasdaq: CALA) Shares Jump on Incyte Deal

Calithera Biosciences, Inc. – Nasdaq: CALA

News of a global collaboration and licensing agreement between Incyte Corporation (Nasdaq: INCY) and Calithera Biosciences (Nasdaq: CALA) has sent the latter’s shares up over 30% in pre-market trading on moderate volumes. Terms of the deal gives Calithera a $45 million payment and an $8 million equity investment in exchange for Incyte gaining global rights to Caslithera’s CB-1158. Additionally, both companies will fund development of CB-1158 while Calithera will be eligible to share in U.S. profits.

Incyte Corporation develops proprietary therapeutics in oncology in the United States and internationally. Calithera Biosciences, Inc. is a clinical-stage biopharmaceutical company that develops treatments utilizing small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer in the United States.

Calithera Biosciences has no reported sales. CALA EPS has been negative since 2012 and lost $1.81 in 2015. Two firms follow Calithera and rate CALA as a “Strong Buy” with a consensus price target of $9.  

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.

1/30/2017
Ticker Symbol CALA
Last Price a/o 8:55 AM EST  $                      6.00
Average Volume 300,180
Market Cap 95.4 million
Sales
Shares Outstanding 20.74 million
Share Float 20.29 million
Shortable Yes
Optionable Yes
Inside Ownership 0.40%
Short Float 4.60%
Short Interest Ratio 3.11
Quarterly Return 100.00%
YTD Return 41.54%
Year Return -6.88%

Air Transport Services Group (Nasdaq: ATSG) Higher After Lowering Guidance

Air Transport Services Group, Inc. – Nasdaq: ATSG

Shares of Wilmington, OH-based Air Transport Services Group are over 9% higher a day after the air transport company lowered guidance for the 4th quarter and all of 2016 due to a work stoppage by the pilots of a subsidiary. ATSG, traded on the Nasdaq, gapped lower to open at $15.14 but rose to $17.04 as of this writing.

ATSG is a provider of aircraft leasing and air cargo transportation and related services to domestic and foreign air carriers and other companies that outsource their air cargo lift requirements. ATSG, through its leasing and airline subsidiaries, is the world’s largest owner and operator of converted Boeing 767 freighter aircraft. Through its principal subsidiaries, including two airlines with separate and distinct U.S. FAA Part 121 Air Carrier certificates, ATSG provides aircraft leasing, air cargo lift, aircraft maintenance services and airport ground services.

In 2015 EPS for ATSG was $0.61 on sales of $619.3 million. Three firms follow ATSG. Two rate the shares as a “Strong Buy” and one rates ATSG as a “Hold”. Their consensus price target is $18.

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.

 

MoneyGram Int’l (Nasdaq: MGI) Shares Jump on Acquisition Offer, Fall on Investigation

MoneyGram International, Inc. – Nasdaq: MGI

 Drama surrounded shareholders of MoneyGram International today. First came an announcement that shareholders will be being offered $13.25 per share in cash by Ant Financial – Alibaba’s online payments and financial services arm. This $880 million deal represents an 11.5% premium to Wednesday’s MGI closing price. However, at the same time, New York law firm Harwood, Feffer LLP announced it is investigating potential claims against the board of directors of MoneyGram International concerning the proposed acquisition. Their concern centers around the issue of whether or not the Board of MoneyGram International fulfilled its fiduciary duty to maximize shareholder value.

The acquisition announcement of MGI gapped shares up this morning to open at $13. However, MGI shares quickly lost momentum and settled at $12.92. After-hours trading volume has been heavy but shares remained unchanged as of this writing.

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.

 

Pulmatrix Inc. (Nasdaq: PULM) Continues Rise Amid Massive Volumes

Pulmatrix, Inc. – Nasdaq: PULM

At the beginning of the year, Pulmatrix Inc. was trading in the $0.50 handle. However, the last several days have seen a massive increase in volume and a rise in price to an inter-day high of over $2.50 – a gain of 62%+ just this week. PULM, traded on the Nasdaq, had an average daily volume of over 650,000 shares but today volumes are over 16 million.

Pulmatrix is a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary disease using its patented iSPERSE™ technology. The Company’s proprietary product pipeline is focused on advancing treatments for lung diseases, including opportunities in major pulmonary diseases through collaborations.

The most recent news came on January 17, 2017. Pulmatrix announced its drug candidate for treating fungal infections in the lungs of CF patients, PUR1900, has been designated as a “Qualified Infectious Disease Product” (QIDP) by the U.S. Food & Drug Administration.

Pulmatrix and PULM shares are not covered or rated by any firms. PULM ended yesterday at $1.64 and is currently trading above $2.40.

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.

1/26/2017
Ticker Symbol PULM
Last Price a/o 12:58 PM EST  $                      2.45
Average Volume 657,800
Market Cap $24.36 million
Sales $1.00 million
Shares Outstanding 14.85 million
Share Float 13.19 million
Shortable Yes
Optionable No
Inside Ownership 26.44%
Short Float 0.15%
Short Interest Ratio 0.03
Quarterly Return 17.14%
YTD Return 177.97%
Year Return -43.45%

Monster Digital (Nasdaq: MSDI) Volumes Explode on Heels of Magazine Article

Monster Digital, Inc. – Nasdaq: MSDI

Nano-cap Monster Digital, Inc. shares are experiencing massive volumes. Average daily volume for MSDI, traded on the Nasdaq, is 84,000 but today volumes have jumped to over 2 million in morning trading.

Simi Valley, CA-based Monster Digital designs and engineers action sports cameras and accessories.   The company also produces advanced data storage and memory products.  Their memory card products for cameras, mobile devices, and tablets feature rugged construction, rapid transfer rates, and capacities that strive get the best performance out of each device.

One possible reason that shares are higher on huge volumes is the publication of an article yesterday in a Canadian magazine – WIFI HIFI Magazine. They offered a positive review of some of Monster Digital products.

No firms follow or rate Monster Digital or MSDI shares.

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.

MicroVision Inc. (Nasdaq: MVIS) Shares Higher On Analyst Price Target

MicroVision, Inc. – Nasdaq: MVIS

MicroVision, Inc. shares are trading 7% higher on an analyst giving the shares a $4.50 price target. MVIS shares, traded on the Nasdaq, have not traded above $5 since 2011 and ended yesterday modestly higher at $1.26.

Redmond, WA-based MicroVision is the creator of PicoP® scanning technology, an ultra-miniature laser projection and imaging solution based on proprietary laser beam scanning methodology. The platform approach for this display and imaging solution means that it can be adapted to a wide array of applications and form factors. MicroVision licenses their patented technology to companies that develop and manufacture high tech components and end user products. MicroVision’s PicoP scanning technology acts as a catalyst for product ideas for companies. Extensive research has led MicroVision to become an independently recognized by IEEE, the Patent Board as a top 50 IP portfolio among global industrial companies and has been included in the Ocean Tomo 300 Patent Index.

MVIS shares have never experienced positive EPS but the losses have been steadily narrowing since 2011 and last year MVIS had their best reported sales since 2011 – $9.2 million. Three firms follow MVIS and all rate the shares as a “Strong Buy” with a consensus price target of $3.50.

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.

 

Endologix Inc. (Nasdaq: ELGX) Up on Good News

Endologix, Inc. – Nasdaq: ELGX

Endologix, Inc. shares are up over 10% on heavy volumes. This price action comes as news surfaces that it received notice from its Notified Body in the European Union that the CE Mark for the AFX® and AFX2 Endovascular AAA Systems has been reinstated, effective immediately.

John McDermott, Chief Executive Officer of Endologix, said, “We are pleased that AFX and AFX2 are once again available to physicians and patients in Europe. The quick reinstatement of the CE Mark is a testament to the strong commercial clinical results achieved with the current generations of the device.  Additionally, during this process we received numerous letters and endorsements from physicians worldwide and we’d like to thank them for their support.”

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.”

Nine firms follow Endologix. Five assign ELGX shares as a “Strong Buy” and four rate the shares as a “Hold”. Their consensus price target for ELGX is $10.

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.

1/25/2017
Ticker Symbol ELGX
Last Price a/o 3:29 PM EST  $                      6.82
Average Volume 2.47 million
Market Cap $518.63 million
Sales 184.7 million
Shares Outstanding 83.92 million
Share Float 80.7 million
Shortable Yes
Optionable Yes
Inside Ownership 1.40%
Short Float 20.02%
Short Interest Ratio 6.54
Quarterly Return -50.44%
YTD Return 8.04%
Year Return -19.32%

Arctic Cat Inc. (Nasdaq: ACAT) Acquired by Textron (NYSE: TXT)

Arctic Cat, Inc. – Nasdaq: ACAT

Arctic Cat, Inc., traded on the Nasdaq under ticker ACAT, has agreed to be purchased by Textron (NYSE: TXT) in an all-cash $247 million deal. The terms of the transaction represent a 40%+ premium to ACAT’s closing price on January 20, 2017.

Christopher Metz, Arctic Cat’s president and chief executive officer stated in a press release “Arctic Cat’s board believes that Textron’s offer delivers compelling and immediate value to our shareholders. This transaction presents increased opportunities for the business to leverage our combined scale, accelerate growth and enhance product innovation in ways that will benefit our customers, dealers and employees.”

Providence, RI-based Textron is a multi-industry company that generates over $13 Billion in annual revenues. ACAT traded at $18.48 in the Nasdaq pre-market at 7:08 AM EST. The per share buyout price for ACAT is $18.50. 

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.